Newsroom

For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

A group of high school students learning about the brain.
Educational neuroscience research cluster growing in numbers and influence Nov 9, 2018

“In the beginning, we were just thinking about children, and how education affects kids’ brains,” said Dr. Lara Boyd, one of the original principal investigators with the Educational Neuroscience and Healthy Child Development Research Cluster. “Now our cluster has grown to four or five times its original size and we’re widening our original scope.”

+
Leili Mortazavi demonstrates aspects of her research in the lab with Sukhbir Kaur, Winstanley lab manager.
Motivation, decision-making, and telling our stories anyway Nov 2, 2018

Pictured: Leili Mortazavi (left) and Sukhbir Kaur (right), research technician in Dr. Catharine Winstanley's lab.

+
Dr. Mark Cembrowski.
New faculty member recognized as Next Generation Leader by Allen Institute Nov 2, 2018

The Allen Institute in Seattle announced today their 2018 Next Generation Leaders, a group of six early-career neuroscientists who will participate in a special advisory council for the Allen Institute for Brain Science, a division of the Allen Institute.

+
Drs MacVicar, Sossi and Mackay outside the DMCBH as the new PET/MRI is delivered on October 30.
Member news: October 2018 Oct 31, 2018

Pictured (left to right): Dr. Brian MacVicar, Dr. Vesna Sossi, and Dr. Alex Mackay stand outside the Djavad Mowafaghian Centre for Brain Health as the new PET/MRI is delivered on October 30, 2018.

+
Dr. Anthony Traboulsee consults a patient in the UBC Hospital MS Clinic.
Clinical trial results put liberation therapy controversy to rest Oct 30, 2018

For Dr. Anthony Traboulsee (pictured above), Director of the UBC MS & NMO Research Program at the Djavad Mowafaghian Centre for Brain Health and lead investigator on two Canada-wide clinical trials to determine the efficacy of liberation therapy in MS, it was an opportunity to listen to the community.

+
Mature woman playing a slot machine game in a casino.
Casino lights and sounds encourage risky decision-making Oct 29, 2018

Are the blinking lights and exciting jingles ubiquitous on the casino floor just a little bit of harmless ambience-building razzle dazzle, or could they affect your choices and actions when you gamble with slot machines? New research demonstrates that the sights and sounds of the casino may directly influence decision-making and behaviour, encouraging riskier choices.

+
Woman looks out window specked with rain.
Collaboration builds resources to heal after leading cause of brain injury in women Oct 15, 2018

When we think of concussion, it’s easy to imagine that traumatic brain injury occurs most often in ice rinks and on playing fields, or that it’s an issue that disproportionately affects professional athletes or rambunctious children. In fact, 25 per cent of traumatic brain injuries occur in women, and intimate partner violence may be one of the leading causes of concussion for women in Canada.

+
Mother (right) with two young adult daughters.
Motherhood could affect hormone therapy’s ability to prevent memory loss Oct 11, 2018

Researchers have established that the foggy feeling and forgetfulness that many new mothers report during and after pregnancy—known as “mom brain”—is real. But new findings from Dr. Liisa Galea and her team at the University of British Columbia suggest that the effect of motherhood on the brain appears to last much longer after childbirth than previously believed.

+
Dr. Judy Illes
Neuroethics Canada awarded funds to develop strategy for evaluating new treatment options for pediatric epilepsy Sep 26, 2018

A team led by Neuroethics Canada's Dr. Judy Illes (pictured) and Dr. Patrick McDonald will explore ethical issues confronting families and clinicians when considering new treatment options for drug-resistant epilepsy in children.

+

Pages